[1]
S. Vishal, “Comparative evaluation of cost-effectiveness between typical antipsychotic haloperidol and atypical antipsychotics olanzapine, risperidone and aripiprazole in the treatment of stable schizophrenia”, Int J Basic Clin Pharmacol, vol. 6, no. 8, pp. 1965–1968, Jul. 2017.